In this article published in The Pink Sheet, Tim Wilsdon and Ryan Lawlor explore the relationship between various procurement models and vaccine coverage rates in Europe. They discuss how certain procurement methods help contribute to a sustainable “vaccine ecosystem.”
To read the article, click here.
Note: subscription required to access
Rare disease PMA trends in France: Price achieved vs. disease prevalence
In this installment, we examine the relationship between launch prices in France and disease prevalence as reported in the Haute Autorité de Santé assessments.